Anixa Biosciences, Inc.
ANIX · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $12 | $29 |
| Short-Term Investments | $19 | $23 | $17 | $7 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$0 | $0 |
| Other Curr. Assets | $1 | $1 | $0 | $0 |
| Total Curr. Assets | $21 | $25 | $30 | $36 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22 | $26 | $30 | $36 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $2 | $1 |
| Total Curr. Liab. | $3 | $2 | $2 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3 | $2 | $2 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$241 | -$228 | -$218 | -$205 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $260 | $252 | $247 | $240 |
| Total Equity | $20 | $24 | $29 | $35 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $22 | $26 | $30 | $36 |
| Net Debt | -$1 | -$1 | -$12 | -$29 |